Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer

American Journal of Pathology

Volumn 149, Issue 5, 1996, Pages 1565-1573

  Huang, Shiu Feng ^a,d   Xiao, Sheng ^a   Renshaw, Andrew A ^a   Loughlin, Kevin R ^a   Hudson, Thomas J ^b   Fletcher, Jonathan A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 8P; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROSTATIC NEOPLASMS;

EID: 0029911967     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Brothman AR, Peehl DM, Patel AM, McNeal JE: Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 1990, 50:3795-3803
2. Atkin NB, Baker MC: Chromosome 10 deletion in carcinoma of the prostate. N Engl J Med 1985, 312:315
3. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F: Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes & Cancer 1992, 4:16-24
4. Sandberg AA: Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 1992, 23:368-380
5. Konig JJ, Teubel W, van Dongen JW, Hagemeijer A, Romijn JC, Schroder FH: Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chromosomes & Cancer 1993, 8:22-27
6. Brothman AR, Patel AM, Peehl DM, Schellhammer PF: Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 1992, 62:180-185
7. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR: Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 1993, 69:7-12
8. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR: Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosomes & Cancer 1994, 11:163-170
9. Bergerheim US, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes & Cancer 1991, 3:215-220
10. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993, 53:3869-3873
11. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R: Loss of chromosome arm Bp loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes & Cancer 1994, 10:151-159
12. Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 1994, 54:6061-6064
13. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ: Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995, 55: 5390-5395
14. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990, 87:8751-8755
15. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD: Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 1994, 54:3273-3277
16. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995, 55:342-347
17. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH: Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes & Cancer 1994, 11:153-162
18. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P: Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes & Cancer 1995, 14:267-276
19. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995, 55:2959-2962
20. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR: Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosomes & Cancer 1993, 8:88-97
21. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP: Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 1994, 145:624-630
22. Brothman AR, Watson MJ, Zhu XL, Williams BJ, Rohr LR: Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 1994, 75:40-44
23. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US: Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 1994, 9:3071-3076
24. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994, 54:3824-3830
25. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB: Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994, 54:3574-3579
26. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994, 54:3998-4002
27. Xiao S, Li D, Vijg J, Sugarbaker DJ, Corson JM, Fletcher JA: Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 1995, 11:511-515
28. Schofield DE, Fletcher JA: Trisomy 12 in pediatric granulosa-stromal cell tumors: demonstration by a modified method of fluorescence in situ hybridization on paraffinembedded material. Am J Pathol 1992, 141:1265-1269
29. Xiao S, Renshaw AA, Cibas ES, Hudson TJ, Fletcher JA: Novel fluorescence in situ hybridization approaches in solid tumors: characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol 1995, 147:896-904
30. Lengauer C, Riethman HC, Speicher MR, Taniwaki M, Konecki D, Green ED, Becher R, Olson MV, Cremer T: Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2. Cancer Res 1992, 52:2590-2596
31. Cohen D, Chumakov I, Weissenbach J: A first-generation physical map of the human genome. Nature 1993, 366:698-701
32. Lichter P, Tang CJ, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990, 247:64-69
33. Hopman AH, Ramaekers FC, Raap AK, Beck JL, Devilee P, van der Ploeg M, Vooijs GP: In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988, 89:307-316
34. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site, and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597
35. Walker GJ, Palmer JM, Walters MK, Hayward NK: A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes & Cancer 1995, 12:134-141
36. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264:436-440
37. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, Meltzer SJ: The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 1994, 9:3737-3741
38. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade Ol: Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 1994, 54:2060-2063
39. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR: Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 1993, 53:4349-4355
40. Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sidransky D: Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 1994, 54. 2322-2326
41. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S: Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes & Cancer 1995, 12:173-185
42. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y: Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 1992, 7:445-449
43. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM: The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996, 85:17-26
44. Sreekantaiah C, Bhargava MK, Shetty NJ: Chromosome 1 abnormalities in cervical carcinoma. Cancer 1988, 62:1317-1324
45. Poddighe PJ, Ramaekers FC, Smeets AW, Vooijs GP, Hopman AH: Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Cancer Res 1992, 52:4929-4934
46. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ: Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia. Genes Chromosomes & Cancer 1994, 10:286-288
47. Orphanos V, McGown G, Hey Y, Boyle JM, Santibanez-Koref M: Proximal 6q, a region showing allele loss in primary breast cancer. Br J Cancer 1995, 71:290-293
48. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J: Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991, 51:5449-5453
49. Fletcher JA, Gebhardt MC, Kozakewich HP: Cytogenetic aberrations in osteosarcomas: nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet 1994, 77:81-88
50. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J: Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 1994, 54:5643-5648
51. Flejter WL, Li FP, Antman KH, Testa JR: Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes. Genes Chromosomes & Cancer 1989, 1:148-154
52. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 1990, 50:5863-5867
53. Hoang-Xuan K, Merel P, Vega F, Hugot JP, Cornu P, Delattre JY, Poisson M, Thomas G, Delattre O: Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 1995, 60:478-481
54. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu S, Colbert AME, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Gaiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton LT, Anderson MO, Collymore AJ, Ye W, Kouyoumijian V, Zemsteva IS, Tarn J, Devine R, Courtney DF, Renaud MT, Nguyen H, O'Connor TJ, Fizames C, Faure S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenbach J, Hawkins TL, Foote S, Page DC, Lander ES: An STS-based map of the human genome. Science 1995, 270: 1945-1954